Rybelsus, an oral glucagon-like peptide-1 (GLP-1) medication for Type 2 diabetes, is being phased out as the manufacturer introduces a newer oral semaglutide formulation under the Ozempic brand name.

What to Expect

The Ozempic pill is a newer oral version of semaglutide, the same active ingredient found in Rybelsus tablets and Ozempic injections. The main difference is how it’s formulated. The Ozempic pill is designed to improve absorption, which means it can provide a similar effect at a lower dose than Rybelsus.

If you’re currently taking Rybelsus, it’s recommended to talk to your prescriber about switching to the Ozempic pill, as appropriate. Switching from one to the other is usually straightforward, but there are a few key things to keep in mind. You’ll need a new prescription, and your dose will change.

Rybelsus and Ozempic pills have the same dosage instructions, which are important for the medication to work properly. Side effects are usually similar, and include nausea, vomiting, diarrhea, constipation, and stomach upset.

Saving on the Ozempic Pill

If you’re switching to the Ozempic pill, you may be concerned about cost. There may be several ways to lower your out-of-pocket cost, including saving with a copay card or home delivery.

Original reporting: KTBS 3 (Shreveport) — read the source article.